Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease.

Hangkai HuangYanjun GuoZhening LiuYan ZengYishu ChenCheng-Fu Xu

Published in: The Journal of clinical endocrinology and metabolism (2022)

Remnant cholesterol was independently associated with the risk of MAFLD and predicted all-cause, cardiovascular, and cancer-related mortalities in MAFLD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
low density lipoprotein
prognostic factors
oxidative stress
cardiovascular disease
type diabetes
patient reported